Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo

Summary

Urokinase-type plasminogen activator (u-PA) and plasminogen play a primary role in liver repair through the accumulation of macrophages and alteration of their phenotype. However, it is still unclear whether u-PA and plasminogen mediate the activation of macrophage phagocytosis during liver repair. Herein, we investigated the morphological changes in macrophages that accumulated at the edge of damaged tissue induced by a photochemical reaction or hepatic ischaemia-reperfu-sion in mice with u-PA (u-PA^−/− ) or plasminogen (Plg^−/− ) gene deficiency by using transmission electron and fluorescence microscopy. In wild-type mice, the macrophages aligned at the edge of the damaged tissue and extended a large number of long pseudopodia. These macrophages clearly engulfed cellular debris and showed well-developed organelles, including lysosome-like vacuoles, nuclei, and Golgi complexes. In wild-type mice, the distribution of the Golgi complex in these macrophages was biased towards the direction of the damaged tissue, indicating the extension of their pseudopodia in this direction. Conversely, in u-PA^−/− and Plg^−/− mice, the macrophages located at the edge of the damaged tissue had few pseudopodia and less developed organelles. The Golgi complex was randomly distributed in these macrophages in u-PA^−/− mice. Furthermore, interferon γ and IL-4 were expressed at a low level at the border region of the damaged tissue in u-PA^−/− mice. Our data provide novel evidence that u-PA and plasminogen are essential for the phagocytosis of cellular debris by macrophages during liver repair. Furthermore, u-PA plays a critical role in the induction of macrophage polarity by affecting the microenvironment at the edge of damaged tissue.

Keywords

u-PA - plasminogen - macrophage - phagocytosis - liver repair

• References

• 1 Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
• 2 Megens RT, Kemmerich K, Pyta J. et al. Intravital imaging of phagocyte recruitment. Thromb Haemost 2011; 105: 802-810.
• 3 Sokol RJ, Hudson G, James NT. et al. Human macrophage development: a morphometric study. J Anat 1987; 151: 27-35.
• 4 Krombach F, Gerlach JT, Padovan C. et al. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J 1996; 09: 984-991.
• 5 Cocco RE, Ucker DS. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell 2001; 12: 919-930.
• 6 Brouckaert G, Kalai M, Krysko DV. et al. Phagocytosis of necrotic cells by macro-phages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell 2004; 15: 1089-1100.
• 7 Poon IK, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010; 17: 381-397.
• 8 Kupfer A, Louvard D, Singer SJ. Polarization of the Golgi apparatus and the microtubule-organizing center in cultured fibroblasts at the edge of an experimental wound. Proc Natl Acad Sci USA 1982; 79: 2603-2607.
• 9 Yadav S, Puri S, Linstedt AD. A primary role for Golgi positioning in directed secretion, cell polarity, and wound healing. Mol Biol Cell 2009; 20: 1728-1736.
• 10 Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 03: 23-35.
• 11 Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76: 509-513.
• 12 Stout RD, Jiang C, Matta B. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005; 175: 342-349.
• 13 Mosser DM, Edwards J P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 08: 958-969.
• 14 Wolfs IM, Donners MM, de Winther M P. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb Haemost 2011; 106: 763-771.
• 15 Kawao N, Nagai N, Tamura Y. et al. Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice. Thromb Haemost 2011; 105: 892-900.
• 16 Bezerra JA, Bugge TH, Melin-Aldana H. et al. Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. Proc Natl Acad Sci USA 1999; 96: 15143-15148.
• 17 Bezerra JA, Currier AR, Melin-Aldana H. et al. Plasminogen activators direct reorganization of the liver lobule after acute injury. Am J Pathol 2001; 158: 921-929.
• 18 Ng VL, Sabla GE, Melin-Aldana H. et al. Plasminogen deficiency results in poor clearance of non-fibrin matrix and persistent activation of hepatic stellate cells after an acute injury. J Hepatol 2001; 35: 781-789.
• 19 Okada K, Ueshima S, Imano M. et al. The regulation of liver regeneration by the plasmin/alpha 2-antiplasmin system. J Hepatol 2004; 40: 110-116.
• 20 Kawao N, Okada K, Kawata S. et al. Plasmin decreases the BH3-only protein BimEL via the ERK1/2 signaling pathway in hepatocytes. Biochim Biophys Acta 2007; 1773: 718-727.
• 21 Shimizu M, Hara A, Okuno M. et al. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 2001; 33: 569-576.
• 22 Shanmukhappa K, Matte U, Degen JL. et al. Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. J Biol Chem 2009; 284: 12917-12923.
• 23 Kawao N, Nagai N, Ishida C. et al. Plasminogen is essential for granulation tissue formation during the recovery process after liver injury in mice. J Thromb Hae-most 2010; 08: 1555-1566.
• 24 Kawao N, Nagai N, Okada K. et al. Role of plasminogen in macrophage accumulation during liver repair. Thromb Res 2010; 125: e214-221.
• 25 Nagai N, Kawao N, Oka da K. et al. Initial brain lesion size affects the extent of subsequent pathophysiological responses. Brain Res 2010; 1322: 109-117.
• 26 Carmeliet P, Schoonjans L, Kieckens L. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-424.
• 27 Ploplis VA, Carmeliet P, Vazirzadeh S. et al. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-2593.
• 28 Umemura K, Kohno Y, Matsuno H. et al. A new model for photochemically induced thrombosis in the inner ear microcirculation and the use of hearing loss as a measure for microcirculatory disorders. Eur Arch Otorhinolaryngol 1990; 248: 105-108.
• 29 Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
• 30 Erlandsson Harris H, Andersson U. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004; 34: 1503-1512.
• 31 Ploplis VA, French EL, Carmeliet P. et al. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998; 91: 2005-2009.
• 32 Bryer SC, Fantuzzi G, Van Rooijen N. et al. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol 2008; 180: 1179-1188.